Dopamine beta-hydroxylase inhibitor (undisclosed)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dopamine beta-hydroxylase inhibitor (undisclosed), covering 2014-12-09 to 2014-12-09. Get the full timeline:
Most recent: Clinical Trial Update: A PET Exploration of the Mechanism of Action of Dopamine Beta-hydroxylase Inhibition in Cocaine Addicts [Phase 4]